Abstract

This study employs machine learning and population data for testing the associations of preterm birth with inflammatory bowel disease (IBD), salivary gland disease, socioeconomic status and medication history, including proton pump inhibitors. The source of population-based retrospective cohort data was the Korea National Health Insurance Service claims data for all women aged 25–40 years and who experience their first childbirths as singleton pregnancy during 2015 to 2017 (402,092 women). These participants were divided into the Ulcerative Colitis (UC) Group (1782 women), the Crohn Group (1954 women) and the Non-IBD Group (398,219 women). For each group, the dependent variable was preterm birth during 2015–2017, and 51 independent variables were included. Random forest variable importance was employed for investigating the main factors of preterm birth and testing its associations with salivary gland disease, socioeconomic status and medication history for each group. The proportion of preterm birth was higher for the UC Group and the Non-IBD Group than for the Crohn Group: 7.86%, 7.17% vs. 6.76%. Based on random forest variable importance, salivary gland disease was a top 10 determinant for the prediction of preterm birth for the UC Group, but this was not the case for the Crohn Group or the Non-IBD Group. The top 5 variables of preterm birth for the UC Group during 2015–2017 were socioeconomic status (8.58), age (8.00), proton pump inhibitors (2.35), progesterone (2.13) and salivary gland disease in 2014 (1.72). In conclusion, preterm birth has strong associations with ulcerative colitis, salivary gland disease, socioeconomic status and medication history including proton pump inhibitors.

Highlights

  • Preterm birth and inflammatory bowel disease (IBD) are major parts of the disease burden on the globe [1–9]

  • The proportion of preterm birth was higher for the ulcerative colitis (UC) Group and the Non-IBD Group than for the Crohn Group: (1) 7.52%, 6.90% vs. 6.60% (PTB 3); (2) 7.86%, 7.17% vs. 6.76% (PTB 4); (3) 0.34%, 0.27% vs. 0.16% (PTB 4 excluded in PTB 3)

  • Preterm birth had a stronger association with UC than with Crohn’s disease in a previous study [16]. This agrees with the result of this study: The proportion of preterm birth was higher for the UC Group and the Non-IBD Group than for the Crohn Group

Read more

Summary

Introduction

Preterm birth and inflammatory bowel disease (IBD) are major parts of the disease burden on the globe [1–9]. 15 million babies are born preterm in the world, and preterm birth is a main contributor for global neonatal and childhood mortality, i.e., 1 million deaths among those aged 0 to 4 years [1,2]. 10 babies was preterm in the United States during 2003–2012, that is, 5,042,982 (12.2%) of. Cost-effective interventions are expected to prevent three-quarters of mortality from preterm birth [4]. During 1990–2017, the global prevalence of IBD registered a rapid growth of 85.1% from 3.7 million to 6.8 million. IBD (or “non-infectious chronic inflammation of the gastrointestinal tract”) includes ulcerative colitis (UC) and

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call